Board
MATTIAS LUNDIN
Chairman
Chairman since 2021

- Born: 1968
- Education: Marketing economist from IHM Business School in Stockholm.
- Experience: Mattias Lundin is CEO of Lumito AB (listed on NGM Nordic SME), and has previously, among other things, been Vice President of Global Sales at CellaVision AB and held a number of positions within the ArjoHuntleigh Group, most recently Vice President Commercial for International Mature Markets.
- Other ongoing assignments: Phase Holographic Imaging PHI AB (publ) Neola Medical AB (publ).
- Holdings: 39,851 shares and 4,851 TO2.
Independent in relation to the Company and its management and the Company's major shareholders.
LARS JOHANSSON
Board member
Board member of ProstaLund since May 2022.

- Born: 1966
- Education: Master of Science in Business and Economics (M.Sc).
- Experience: Lars Johansson has more than 29 years of experience from the Johnson & Johnson Group. He has a broad experience in sales and marketing as well as business management from both Medtech and pharmaceuticals. He has been CEO of Johnson & Johnson AB and Janssen Cilag AB. Lars Johansson has attended Michaël Berglund's training Professional Board work.
- Other ongoing assignments: Board member of Schain Research AB, Mailo Global AB, MILA The bigger picture AB.
- Previous assignments (past five years): Board member of LIF, the researching pharmaceutical companies.
- Holdings: 92,486 shares och 5,003 st. TO2.
Independent in relation to the Company and its management and the Company's major shareholders.
SONNY SCHELIN
Board member
Board memeber of ProstaLund since 2012.

- Born: 1945
- Education: Trained physician and specialist in urology.
- Experience: Sonny Schelin is a trained physician and specialist in general surgery and urology and has defended his thesis on microwave treatment of benign prostatic hyperplasia in Lund in 2006. Founder of the Specialist Medical Group in Kalmar and has extensive experience in prostate diseases and various treatment methods. Sonny Schelin is the inventor of PLFT,® Schelin Catheter®, CoreTherm® energy dosing and CoreFlow® Soft Stent and has further developed ProstaLund's treatment method to today's standards.
- Other ongoing assignments: : CEO and board member of Schelin Medicin AB and Schelin Medicin Sweden AB. Deputy board member of Nordisk Medicin & Teknik AB.
- Holdings: 2,473,110 shares and 301,058 TO2 (via company and private).
Dependent in relation to the Company and its management and the Company's major shareholders, respectively.
MATS ALYHR
Board member
Board member of ProstaLund since May 2022

- Born: 1984
- Education: Technology program, high school.
- Experience: Mats Alyhr, born 1984, is a driven entrepreneur and entrepreneur from Gotland. Owns and operates, among other things, the unlisted companies Aktiebolaget Henrik Alyhr and Flyttstädningsakuten AB. Experience in corporate development, the tourism industry, web development and specially adapted solutions in IT. The largest single shareholder in ProstaLund AB, currently has a holding of just over 20% of the company's shares (private and via companies).
- Other ongoing assignments CEO and/or board member of Aktiebolaget Henrik Alyhr, Flyttstädningsakuten AB, Alyhr Holding AB, Solia i Visby AB, Mats Alyhr AB, Gotlands Floristmästare AB.
- Holdings: 13,831,111 shares and 1,676,386. TO2 (via company/endowment insurance and private).
Dependent in relation to the Company and its management and the Company's major shareholders, respectively.
MARIANNE ÖSTLUND
Board member
Board member since 2020

- Born: 1964
- Education: Gothenburg School of Economics.
- Experience: Solid experience in marketing and PR at national and international levels. She has many years of experience in board assignments by both listed and unlisted companies as well as associations. She also has valuable expertise from political work and lobbying at municipal, county and national levels. Deep knowledge of medical technology, pharmaceuticals and health care. After political work in the Swedish parliament, Marianne started a successful PR agency in 1994 that handled large national and international assignments such as crisis management, product launches, lobby campaigns, IPOs and brand campaigns. She and the agency have received several awards for, among other things, attitude campaigns in health.
- Other ongoing assignments:Peptonic Medical AB (publ), 1.6 million club AB, First Communication AB and Effektiv Media i Stockholm Aktiebolag.
- Holdings: 67,000 shares.